Tinnitus has relatively few treatments with clinical trial evidence behind them, so a new option is worth understanding properly. Lenire is a treatment device for tinnitus that was included on the Australian Register of Therapeutic Goods in September 2025. It is available through a small number of certified clinics in Australia, including ours.
Below, we cover how Lenire works, the clinical evidence, its limitations, and when it may or may not be appropriate.
What is Lenire
Lenire is a medical device used at home and configured for each patient by an audiologist. It has three parts: a set of Bluetooth headphones, a handheld controller, and a component called a Tonguetip that rests inside the closed mouth.
It is registered with the Therapeutic Goods Administration as a Class IIa medical device, to alleviate the symptoms of chronic, subjective tinnitus in adults aged 18 and over. That wording is worth reading closely. Lenire is intended to reduce how severe and intrusive tinnitus is, not to stop the sound, and it has not been assessed for other forms of tinnitus or for anyone under 18.
Lenire is only available through certified provider clinics. The settings are matched to your hearing and your tinnitus, so a device bought privately or second-hand can’t be configured for you.
How Lenire works
Lenire uses bimodal neuromodulation. This means that headphones play a customised sequence of sounds, which stimulates the auditory nerve, while the Tonguetip delivers mild electrical pulses to the surface of the tongue.
Pairing the two signals has shown to influence how the brain processes sound, a property known as neuroplasticity. The intended effect is that the brain gradually gives tinnitus less attention, so it intrudes less on daily life.
This is the same outcome as tinnitus habituation, which is the basis of our tinnitus program. Lenire supports the same process using a device. It doesn’t replace the counselling, sound enrichment and cognitive strategies that the program provides.
You use the device at home for around an hour a day, usually as two 30-minute sessions, over a 12-week course. Sessions are quiet and seated, and most people do them while reading or watching television. Your audiologist sets the sound and stimulation levels, then adjusts them at review appointments.
What the clinical evidence shows
Lenire has undergone rigorous clinical evaluation across multiple large-scale trials and real-world clinical studies. Overall findings consistently demonstrate significant, long-lasting reductions in tinnitus severity for the vast majority of patients, with real-world clinic data showing that 91.5% of 220 patients experienced a clinically meaningful reduction in tinnitus severity. Crucially, controlled trial evidence confirms that bimodal neuromodulation provides substantial relief where sound therapy alone shows limited effect.
For one person, a clinically meaningful reduction might be the difference between noticing tinnitus constantly and noticing it occasionally. That is a significant change in daily life, but it isn’t silence.
Once we have assessed your hearing and your tinnitus, we will give you a clear indication of the level of benefit you can realistically expect. That applies to Lenire as it does to anything else we recommend.
Who Lenire may suit
Lenire is intended for people whose tinnitus has persisted and remains intrusive. In practice, it’s worth discussing if:
Your tinnitus has been present for more than three months
It’s affecting your sleep, your concentration, or your mood
You have already tried sound enrichment, counselling, or hearing aids without the relief you hoped for
You’re able to use the device for around an hour a day across 12 weeks
You’re 18 or over
The time commitment is worth thinking about before you start. The trial results come from participants who used the device consistently, so if daily sessions for 12 weeks aren’t realistic at the moment, it’s better to raise that at the assessment than to find out partway through.
When Lenire isn’t appropriate
Some forms of tinnitus need medical investigation before any treatment is considered. If your tinnitus is pulsatile, meaning you hear your heartbeat, or if it’s audible to another person, or if it comes with significant dizziness or neurological symptoms, those need looking into first. In those situations we will refer you rather than fit a device.
Certain oral conditions and implanted electrical devices may also make Lenire unsuitable.
A hearing assessment comes first in every case. Hearing loss often develops gradually and goes unrecognised, and where it’s present alongside tinnitus, hearing aids frequently deliver substantial benefit on their own. Straining to follow conversation is tiring, and that fatigue is one of the more reliable things to make tinnitus worse. Treating the hearing loss can reduce tinnitus awareness without any other intervention.
We will not recommend a treatment, including Lenire, unless it is clearly indicated.
What a Lenire assessment involves
Your first appointment runs for around 90 minutes. It covers:
A full hearing assessment, if you have not had one recently
A detailed history of your tinnitus, including likely causes and aggravating factors
An evaluation of how your tinnitus is affecting you
A discussion of whether Lenire is likely to help in your case, and what the alternatives
No GP referral is needed to book an assessment.
Why DWM Audiology
DWM Audiology is among the first clinics in Australia to offer Lenire.
Our practice has a long history in the evaluation and management of tinnitus, hyperacusis and acoustic shock, including contributing to The Multidisciplinary European Guideline for Tinnitus: diagnosis, assessment and treatment (Cima et al., 2019) and conducting clinically focused research in an independent private practice setting.
That history shapes how we approach new technology. Lenire settings are matched to your hearing and your tinnitus, so the assessment behind the device matters as much as the device itself.
Lenire is fitted by Kate Moore and Philippa James, who also deliver our tinnitus therapy program.
When to consider a tinnitus assessment
Lenire is among the tinnitus treatments with peer-reviewed clinical trial evidence behind it, and for suitable patients it can reduce how intrusive tinnitus becomes. It is not a cure, and it is not appropriate for everyone who has tinnitus.
If your tinnitus is affecting your sleep, your concentration or your mood, a tinnitus assessment is a reasonable place to start, whether or not a device turns out to be part of it.
Read more about Lenire treatment at DWM Audiology, or call the clinic on (03) 9457 6588 to discuss whether an assessment is appropriate.
Recent Comments